Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 28.77
(-3.84%)
CNY 28.77
(-3.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 920.01 Million CNY | 6.15% |
| 2022 | 866.72 Million CNY | 7.03% |
| 2021 | 809.78 Million CNY | 0.14% |
| 2020 | 808.64 Million CNY | -24.14% |
| 2019 | 1.06 Billion CNY | 4.28% |
| 2018 | 1.02 Billion CNY | 73.08% |
| 2017 | 590.58 Million CNY | 70.58% |
| 2016 | 346.22 Million CNY | -20.62% |
| 2015 | 436.14 Million CNY | -19.9% |
| 2014 | 544.48 Million CNY | -9.01% |
| 2013 | 598.38 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 203.66 Million CNY | 2.22% |
| 2024 Q1 | 199.23 Million CNY | -0.37% |
| 2024 Q3 | 239.55 Million CNY | 17.62% |
| 2023 FY | 920.01 Million CNY | 6.15% |
| 2023 Q3 | 269.2 Million CNY | -5.78% |
| 2023 Q2 | 285.72 Million CNY | 73.06% |
| 2023 Q1 | 165.1 Million CNY | -40.77% |
| 2023 Q4 | 199.97 Million CNY | -25.71% |
| 2022 Q2 | 215.39 Million CNY | 37.91% |
| 2022 Q1 | 156.19 Million CNY | -26.73% |
| 2022 FY | 866.72 Million CNY | 7.03% |
| 2022 Q4 | 278.73 Million CNY | 28.81% |
| 2022 Q3 | 216.39 Million CNY | 0.46% |
| 2021 Q2 | 244.5 Million CNY | 15.85% |
| 2021 Q1 | 211.05 Million CNY | -18.39% |
| 2021 Q3 | 141.04 Million CNY | -42.31% |
| 2021 Q4 | 213.18 Million CNY | 51.15% |
| 2021 FY | 809.78 Million CNY | 0.14% |
| 2020 FY | 808.64 Million CNY | -24.14% |
| 2020 Q4 | 258.61 Million CNY | 28.02% |
| 2020 Q2 | 277.07 Million CNY | 290.63% |
| 2020 Q1 | 70.92 Million CNY | -76.72% |
| 2020 Q3 | 202.02 Million CNY | -27.09% |
| 2019 Q3 | 217.66 Million CNY | -37.96% |
| 2019 Q1 | 192.74 Million CNY | -40.92% |
| 2019 FY | 1.06 Billion CNY | 4.28% |
| 2019 Q4 | 304.68 Million CNY | 39.98% |
| 2019 Q2 | 350.82 Million CNY | 82.01% |
| 2018 Q2 | 304.07 Million CNY | 65.59% |
| 2018 FY | 1.02 Billion CNY | 73.08% |
| 2018 Q4 | 326.22 Million CNY | 56.67% |
| 2018 Q3 | 208.22 Million CNY | -31.52% |
| 2018 Q1 | 183.63 Million CNY | -8.57% |
| 2017 FY | 590.58 Million CNY | 70.58% |
| 2017 Q3 | 133.6 Million CNY | 0.0% |
| 2017 Q4 | 200.84 Million CNY | 50.33% |
| 2016 FY | 346.22 Million CNY | -20.62% |
| 2015 FY | 436.14 Million CNY | -19.9% |
| 2014 FY | 544.48 Million CNY | -9.01% |
| 2013 FY | 598.38 Million CNY | 0.0% |